#5 - Organon & Co. (NYSE:OGN)
Organon & Co is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
- Current Stock Price
- $9.74
- P/E Ratio
- 3.4
- Dividend Yield
- 0.80%
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 3 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $18.00 (84.8% Upside)
